You are here

  • Home
  • Archive
  • Volume 72, Issue 4
  • Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial

Article metrics

Article menu
Inflammatory bowel disease
Original research
Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial

 

Online download statistics by month:

Online download statistics by month: September 2022 to March 2024

AbstractFullPdf
Sep 202220632015543
Oct 202212231192264
Nov 202215921592473
Dec 2022944934280
Jan 2023811796245
Feb 2023633613232
Mar 202310601051347
Apr 2023593574244
May 2023437430207
Jun 2023577550212
Jul 2023549535165
Aug 202311731154152
Sep 202312381218152
Oct 202315291505180
Nov 202313691342217
Dec 202311521121226
Jan 202417101700225
Feb 202416211611210
Mar 202414541453241
Total21728213864815